Singulex Technology

Singulex manages risks by answering critical health questions about disease and therapeutic intervention with our advanced immunodiagnostic products.

Singulex, Inc. has pioneered technology that can quantitatively detect single molecules, such as proteins and metabolites, in complex biological samples. Our technology extends the dynamic range of any immunoassay by orders of magnitude, allowing drug developers to use biomarkers to measure drug efficacy, safety and disease progression.

Singulex has built a strong portfolio of core competencies including systems design, assay development and sample testing.

Erenna™ Immunoassay System

ETAP™ Case Study